Inflammatory Breast Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer
Conditions: Inflammatory Breast Cancer; Human Epidermal Growth Factor 2 Negative Carcinoma of BreastInterventions: Drug: Eribulin; Drug: Adriamycin; Drug: CyclophosphamideSponsors: Dana-Farber Cancer Institute; Eisai Inc.Not yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2015 Category: Research Source Type: clinical trials
